Products
Platform
Research
Market
Learn
Gland Pharma Ltd Financials Statements
Annual and Quarterly P/L, Balance Sheet, Cash Flow & Financial Ratios
Consolidate
Standalone
Total Qtr Revenue cr | 1,571.04 | 1,563.15 | 1,468.94 | 1,442.55 | 1,465.49 |
| Other Income Qtr Cr | 84.16 | 57.53 | 44.03 | 58.49 | 59.66 |
| Operating Revenues Qtr | 1,486.88 | 1,505.62 | 1,424.91 | 1,384.05 | 1,405.83 |
Loading chart... | |||||
Operating Expenses Qtr | 1,172.99 | 1,137.86 | 1,077.39 | 1,024.10 | 1,108.78 |
Operating Profit Qtr | 313.89 | 367.76 | 347.52 | 359.96 | 297.06 |
EBITDA Qtr Cr | 398.05 | 425.29 | 391.54 | 418.45 | 356.72 |
Depreciation Qtr | 106.31 | 101.05 | 95.76 | 96.32 | 93.83 |
Net Profit Qtr | 183.68 | 215.48 | 186.54 | 204.69 | 163.53 |
Basic EPS Qtr | 11.15 | 13.08 | 11.32 | 12.42 | 9.93 |
Open Demat Account
Open Demat Account